A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
St. Jude Children's Research Hospital
National Cancer Institute (NCI)
Seattle Children's Hospital
GlaxoSmithKline
St. Jude Children's Research Hospital
Fudan University
Iovance Biotherapeutics, Inc.
Children's National Research Institute
Cardinal Health 414, LLC
Memorial Sloan Kettering Cancer Center
National Cancer Institute (NCI)
Bristol-Myers Squibb
Celgene
European Organisation for Research and Treatment of Cancer - EORTC